Stay updated on Nivolumab for Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Cervical Cancer Clinical Trial page.

Latest updates to the Nivolumab for Cervical Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study location list was updated to add Kaiser Permanente-Rio San Diego and remove Kaiser Permanente-San Diego Mission. This reflects a change in site availability and the associated revision to v3.6.6.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe study's listed locations were updated to 331, and the BJC Outpatient Center at Sunset Hills was removed from the list. The study record revision version advanced from v3.6.4 to v3.6.5.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page now shows Revision: v3.6.4 instead of Revision: v3.6.3, signaling a minor backend or formatting update to the study page rather than changes to the study data.SummaryDifference0.0%

- Check71 days agoChange DetectedParticipating sites were updated: Bardstown, East Lexington, and Lahey Clinic were added. At the same time, Flaget Memorial Hospital, Saint Joseph Hospital East, and Lahey Hospital and Medical Center were removed, and the document revision was updated to v3.6.3.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a newer version of the study page and corresponding metadata update.SummaryDifference0.0%

- Check86 days agoChange DetectedCreighton University Medical Center in Omaha, Nebraska was removed; UT MD Anderson Cancer Center was added, and the total number of study locations was updated from 333 to 332.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Cervical Cancer Clinical Trial page.